---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039126"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:45:37.915535+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# N2OFF enters €6M credit facility, pursues spin-off and drug discovery acquisition

## Summary
- €6M non-recourse credit facility at 7% interest; warrant for 1.85M shares at $1.00 exercise price.
- Board approved potential spin-off of cleantech units NTWO OFF and Save Foods into separate public company; N2OFF to retain ≥75% in Save Foods.
- Non-binding LOI to acquire a computationally advanced drug discovery company at valuation of at least $5M (possible $2M increase).
- Acquisition consideration would be cash and equity; company intends to tap new pharmaceutical market.

## SEC filing metadata
- accession: 0001493152-24-039126
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.03, 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315224039126/0001493152-24-039126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315224039126/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039126
- JSON: https://secwatch.observer/filing/0001493152-24-039126.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039126.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
